Abstract 596: IOH-001, a novel CD47/PD-L1 bispecific antibody, enhances anti-tumor activity in solid tumors

MLA

Jeong-kook Kim, et al. “Abstract 596: IOH-001, a Novel CD47/PD-L1 Bispecific Antibody, Enhances Anti-Tumor Activity in Solid Tumors.” Cancer Research, vol. 82, June 2022, p. 596. EBSCOhost, https://doi.org/10.1158/1538-7445.am2022-596.

APA

Jeong-kook Kim, A-Ra Jeon, Jihyun Park, Ji Yea Choi, Ji Eun Park, Sun Kwang Song, Ji Hye Choi, Heewook Shin, Ji Hye Lee, Ji Hye Yun, Yoen Hee Ahn, & Heung Tae Kim. (2022). Abstract 596: IOH-001, a novel CD47/PD-L1 bispecific antibody, enhances anti-tumor activity in solid tumors. Cancer Research, 82, 596. https://doi.org/10.1158/1538-7445.am2022-596

Chicago

Jeong-kook Kim, A-Ra Jeon, Jihyun Park, Ji Yea Choi, Ji Eun Park, Sun Kwang Song, Ji Hye Choi, et al. 2022. “Abstract 596: IOH-001, a Novel CD47/PD-L1 Bispecific Antibody, Enhances Anti-Tumor Activity in Solid Tumors.” Cancer Research 82 (June): 596. doi:10.1158/1538-7445.am2022-596.